Faculty who have authored publication Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial.
Name | Title | Department | Institution |
---|---|---|---|
Timothy Fenske MD | Professor | Medicine | Medical College of Wisconsin |